Back to Top Skip to main content

Pandemic Diseases

Medical Countermeasures (MCM) assumes a proactive, preventive approach to protect service members and their families who may be stationed or deployed in areas at elevated risk to both naturally occurring and manufactured emerging infectious diseases. MCM develops clinical use guidelines for vaccines, diagnostics and antiviral policies that protect the military, civilian personnel and beneficiaries to preserve U.S. combat capabilities and readiness. They also contribute to U.S. government-wide efforts to save lives reduce human suffering and slow the spread of infection. 

This includes managing and updating vaccine use policies to counter infectious disease threats such as smallpox and anthrax, and ensuring the safest and most effective preventive measures are in place to address adenovirus-associated illness and unique regional illnesses such as malaria, Japanese Encephalitis and leishmaniasis.

Photo of U.S. Air Force Staff Sgt. Jon Rigenoldus, 509th Medical Support Squadron medical lab technician, examines samples at Whiteman Air Force Base, Mo., March 18, 2015.

MCM interacts with DoD’s Chemical and Biological Defense Program, to assist in the following:  

  • Development of medical countermeasure requirements 
  • Acquisition processes
  • New product evaluations 
  • Determination of appropriate stockpiling 

MCM ensures that safe, effective medicines are in place and available when needed.

You also may be interested in...

U.S. Government Global Health Security Agenda Partners

Photo
1/29/2016
U.S. Government Global Health Security Agenda Partners

Recommended Content:

Pandemic Diseases | Global Health Engagement
Showing results 1 - 1 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing: Download a PDF Reader or learn more about PDFs.